| scholarly article | Q13442814 |
| P2093 | author name string | Daniel Martin | |
| Julie Langan | |||
| Polash Shajahan | |||
| Rebecca Carleton | |||
| P2860 | cites work | Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial | Q38374708 |
| Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial | Q38379478 | ||
| Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study | Q42882247 | ||
| Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study | Q43469322 | ||
| Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation | Q43974713 | ||
| Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study | Q44022663 | ||
| Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients | Q46616432 | ||
| Who responds to aripiprazole in clinical practice? An observational study of combination versus monotherapy | Q46727012 | ||
| Clinical efficacy of agomelatine in depression: the evidence | Q46911680 | ||
| Efficacy and tolerance profile of agomelatine and practical use in depressed patients | Q46911684 | ||
| Major depressive disorder, sleep EEG and agomelatine: an open-label study | Q48469969 | ||
| Sleep microarchitecture as a predictor of recurrence in children and adolescents with depression | Q48648939 | ||
| Conventional Antipsychotic Prescription in Unipolar Depression, I | Q56595089 | ||
| Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression | Q56992344 | ||
| Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression | Q73076113 | ||
| Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data | Q28248089 | ||
| Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine | Q28259494 | ||
| Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline | Q28274642 | ||
| Agomelatine in the treatment of seasonal affective disorder | Q28279108 | ||
| The clinical global impressions scale: applying a research tool in clinical practice | Q33894649 | ||
| National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 | ||
| Conventional antipsychotic prescription in unipolar depression, I: an audit and recommendations for practice | Q34198257 | ||
| Sleep and psychiatric disorders. A meta-analysis | Q34251440 | ||
| Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder | Q34579202 | ||
| Non-REM sleep instability in patients with major depressive disorder: subjective improvement and improvement of non-REM sleep instability with treatment (Agomelatine). | Q34582696 | ||
| Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review | Q34925071 | ||
| The use of antidepressants in novel combination therapies | Q35081145 | ||
| The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder | Q35854923 | ||
| Bipolar depression: issues in diagnosis and treatment | Q36297923 | ||
| Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods | Q36795521 | ||
| Agomelatine: efficacy at each phase of antidepressant treatment | Q37587162 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | unipolar depression | Q55950055 |
| P304 | page(s) | 175-80 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | Therapeutic advances in psychopharmacology | Q26842244 |
| P1476 | title | Agomelatine in unipolar depression in clinical practice: a retrospective chart review | |
| P478 | volume | 1 |
| Q34040072 | Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials | cites work | P2860 |
Search more.